Citadel Advisors - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,191,841
+17.2%
1,619,784
-12.9%
0.00%0.0%
Q2 2023$6,134,499
+266.7%
1,858,939
+216.7%
0.00%
Q1 2023$1,673,118
-80.2%
587,059
-49.5%
0.00%
-100.0%
Q4 2022$8,456,768
+5.7%
1,161,644
+17.5%
0.00%0.0%
Q3 2022$7,999,000
+192.7%
988,632
+77.3%
0.00%
+100.0%
Q2 2022$2,733,000
-37.8%
557,747
+200.2%
0.00%0.0%
Q1 2022$4,395,000
+19.8%
185,803
-10.4%
0.00%0.0%
Q4 2021$3,668,000
-63.3%
207,361
-41.5%
0.00%
-50.0%
Q3 2021$10,007,000
+132.6%
354,710
-13.6%
0.00%
+100.0%
Q2 2021$4,302,000410,5250.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$10,403,6043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,718,881$25,391,8321.37%
COWEN AND COMPANY, LLC 4,308,359$19,129,1131.34%
RA Capital Management 11,609,704$51,547,0861.02%
RTW INVESTMENTS, LP 5,818,804$25,835,4900.54%
Acuitas Investments, LLC 134,811$598,5610.35%
Simplify Asset Management Inc. 570,519$2,533,1040.29%
Vivo Capital, LLC 520,000$2,308,8000.25%
BRANDYWINE MANAGERS, LLC 26,127$116,0040.20%
DENALI ADVISORS LLC 70,600$313,4640.11%
View complete list of FULCRUM THERAPEUTICS INC shareholders